Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katharina Lechner

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Metabolic Syndrome and Related Disorders|March 3, 2020
High-Risk Atherosclerosis and Metabolic Phenotype: The Roles of Ectopic Adiposity, Atherogenic Dyslipidemia, and InflammationKatharina Lechner, Amy L McKenzie, Nicolle Kränkel, et al.
European Journal of Preventive Cardiology|August 14, 2019
Lifestyle factors and high-risk atherosclerosis: Pathways and mechanisms beyond traditional risk factorsKatharina Lechner, Clemens von Schacky, Amy L McKenzie, et al.
Signal Transduction and Targeted Therapy|August 31, 2025
Arterial stiffness and vascular aging: mechanisms, prevention, and therapyMaximilian Jonathan Herzog, Patrick Müller, Katharina Lechner, et al.
Atherosclerosis|May 18, 2025
Low and high air temperature and cardiovascular riskWenli Ni, Ashtyn T Areal, Katharina Lechner, et al.
Biomedicines|September 23, 2022
Saturated Fatty Acid Blood Levels and Cardiometabolic Phenotype in Patients with HFpEF: A Secondary Analysis of the Aldo-DHF TrialKatharina Lechner, Clemens von Schacky, Johannes Scherr, et al.
Cardiovascular Diabetology|December 9, 2020
Impact of a 2-year trial of nutritional ketosis on indices of cardiovascular disease risk in patients with type 2 diabetesShaminie J Athinarayanan, Sarah J Hallberg, Amy L McKenzie, et al.
Cardiovascular Diabetology|February 6, 2021
Correction to: Impact of a 2‑year trial of nutritional ketosis on indices of cardiovascular disease risk in patients with type 2 diabetesShaminie J Athinarayanan, Sarah J Hallberg, Amy L McKenzie, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 14, 2023
Trans-fatty acid blood levels of industrial but not natural origin are associated with cardiovascular risk factors in patients with HFpEF: a secondary analysis of the Aldo-DHF trialKatharina Lechner, Matthias Bock, Clemens von Schacky, et al.
Metabolic Syndrome and Related Disorders|November 24, 2020
The Effect of Exercise Intensity and Volume on Metabolic Phenotype in Patients with Metabolic Syndrome: A Randomized Controlled TrialPia von Korn, Shelley Keating, Stephan Mueller, et al.
Leukemia & Lymphoma|February 15, 2021
A dose escalation study of RO6870810/TEN-10 in patients with acute myeloid leukemia and myelodysplastic syndromeGail J Roboz, Pinkal Desai, Sangmin Lee, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Metabolic Syndrome and Related Disorders|March 3, 2020
High-Risk Atherosclerosis and Metabolic Phenotype: The Roles of Ectopic Adiposity, Atherogenic Dyslipidemia, and InflammationKatharina Lechner, Amy L McKenzie, Nicolle Kränkel, et al.
European Journal of Preventive Cardiology|August 14, 2019
Lifestyle factors and high-risk atherosclerosis: Pathways and mechanisms beyond traditional risk factorsKatharina Lechner, Clemens von Schacky, Amy L McKenzie, et al.
Signal Transduction and Targeted Therapy|August 31, 2025
Arterial stiffness and vascular aging: mechanisms, prevention, and therapyMaximilian Jonathan Herzog, Patrick Müller, Katharina Lechner, et al.
Atherosclerosis|May 18, 2025
Low and high air temperature and cardiovascular riskWenli Ni, Ashtyn T Areal, Katharina Lechner, et al.
Biomedicines|September 23, 2022
Saturated Fatty Acid Blood Levels and Cardiometabolic Phenotype in Patients with HFpEF: A Secondary Analysis of the Aldo-DHF TrialKatharina Lechner, Clemens von Schacky, Johannes Scherr, et al.
Cardiovascular Diabetology|December 9, 2020
Impact of a 2-year trial of nutritional ketosis on indices of cardiovascular disease risk in patients with type 2 diabetesShaminie J Athinarayanan, Sarah J Hallberg, Amy L McKenzie, et al.
Cardiovascular Diabetology|February 6, 2021
Correction to: Impact of a 2‑year trial of nutritional ketosis on indices of cardiovascular disease risk in patients with type 2 diabetesShaminie J Athinarayanan, Sarah J Hallberg, Amy L McKenzie, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 14, 2023
Trans-fatty acid blood levels of industrial but not natural origin are associated with cardiovascular risk factors in patients with HFpEF: a secondary analysis of the Aldo-DHF trialKatharina Lechner, Matthias Bock, Clemens von Schacky, et al.
Metabolic Syndrome and Related Disorders|November 24, 2020
The Effect of Exercise Intensity and Volume on Metabolic Phenotype in Patients with Metabolic Syndrome: A Randomized Controlled TrialPia von Korn, Shelley Keating, Stephan Mueller, et al.
Leukemia & Lymphoma|February 15, 2021
A dose escalation study of RO6870810/TEN-10 in patients with acute myeloid leukemia and myelodysplastic syndromeGail J Roboz, Pinkal Desai, Sangmin Lee, et al.
Pageof 6